C. Frank Bennett | |
|---|---|
 Bennett in 2018 | |
| Alma mater | University of New Mexico Baylor College of Medicine |
| Awards | Breakthrough Prize in Life Sciences (2019) |
| Scientific career | |
| Fields | Pharmacology |
| Institutions | Ionis Pharmaceuticals |
C. Frank Bennett is an American pharmacologist. Bennett is currently the Senior Vice President of Research and Neurology Franchise Leader at Ionis Pharmaceuticals.[1] He is a 2019 Breakthrough Prize winner in Life Sciences, which he shared with his collaborator Adrian R. Krainer for the development of an effective antisense oligonucleotide therapy for children with the neurodegenerative disease spinal muscular atrophy.[2]
- ^ "C. Frank Bennett, Ph.D." Ionis Pharmaceuticals. 29 May 2014. Retrieved 20 October 2018.
- ^ "Breakthrough Prizes Recognize Aneuploidy Researcher, Biochemist". The Scientist Magazine. 18 October 2018. Retrieved 20 October 2018.